Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A WERNER

Showing results (1131-1140 of 1,356) with videos related to

Pageof 136
Sort By:
Clinical Nuclear Medicine|April 19, 2022
Interobserver Agreement Rates on Fibroblast Activation Protein Inhibitor-Directed Molecular Imaging and TherapySebastian E Serfling, Philipp E Hartrampf, Yingjun Zhi, et al.
Cytogenetics and Cell Genetics|January 1, 1996
Chromosome imbalances in papillary renal cell carcinoma and first cytogenetic data of familial cases analyzed by comparative genomic hybridizationM Bentz, U S Bergerheim, C Li, et al.
European Urology|April 12, 2021
A Systematic Review and Meta-analysis of the Effectiveness and Toxicities of Lutetium-177-labeled Prostate-specific Membrane Antigen-targeted Radioligand Therapy in Metastatic Castration-Resistant Prostate CancerMohammad S Sadaghiani, Sara Sheikhbahaei, Rudolf A Werner, et al.
Clinical Nuclear Medicine|May 5, 2025
Myeloablative Radioligand Therapy Targeting C-X-C Motif Chemokine Receptor 4 in Advanced Multiple MyelomaNiklas Dreher, Anna-Lena Dörrler, Sabrina Kraus, et al.
Journal of Medicinal Chemistry|July 25, 2025
Design, Synthesis and Preclinical Evaluation of a Brain-Permeable PET Tracer for P2Y12 Receptor Imaging in the BrainEmanuel Joseph, Lea H Kunze, Rebecca Schaefer, et al.
Oncotarget|June 4, 2016
The impact of 177Lu-octreotide therapy on 99mTc-MAG3 clearance is not predictive for late nephropathyRudolf A Werner, Seval Beykan, Takahiro Higuchi, et al.
Plant, Cell & Environment|November 24, 2020
Rethinking temperature effects on leaf growth, gene expression and metabolism: Diel variation mattersLukas Kronenberg, Steven Yates, Shiva Ghiasi, et al.
Clinical Nuclear Medicine|February 3, 2015
SPECT- and PET-based patient-tailored treatment in neuroendocrine tumors: a comprehensive multidisciplinary team approachR A Werner, Christina Bluemel, M Lassmann, et al.
Clinical Nuclear Medicine|November 10, 2022
Impact of 68 Ga-FAPI-04 PET/CT on Staging and Therapeutic Management in Patients With Digestive System TumorsAleksander Kosmala, Sebastian E Serfling, Wiebke Schlötelburg, et al.
Neuroimage|April 16, 2026
Dynamic Regional Divergence of SV2A Expression in a Mouse Model of Primary Tauopathy: A Longitudinal Multi-Tracer PET StudyYunlei Li, Artem Zatcepin, Giovanna Palumbo, et al.
Pageof 136

Showing results (1131-1140 of 1,356) with videos related to

Sort By:
Pageof 136
Clinical Nuclear Medicine|April 19, 2022
Interobserver Agreement Rates on Fibroblast Activation Protein Inhibitor-Directed Molecular Imaging and TherapySebastian E Serfling, Philipp E Hartrampf, Yingjun Zhi, et al.
Cytogenetics and Cell Genetics|January 1, 1996
Chromosome imbalances in papillary renal cell carcinoma and first cytogenetic data of familial cases analyzed by comparative genomic hybridizationM Bentz, U S Bergerheim, C Li, et al.
European Urology|April 12, 2021
A Systematic Review and Meta-analysis of the Effectiveness and Toxicities of Lutetium-177-labeled Prostate-specific Membrane Antigen-targeted Radioligand Therapy in Metastatic Castration-Resistant Prostate CancerMohammad S Sadaghiani, Sara Sheikhbahaei, Rudolf A Werner, et al.
Clinical Nuclear Medicine|May 5, 2025
Myeloablative Radioligand Therapy Targeting C-X-C Motif Chemokine Receptor 4 in Advanced Multiple MyelomaNiklas Dreher, Anna-Lena Dörrler, Sabrina Kraus, et al.
Journal of Medicinal Chemistry|July 25, 2025
Design, Synthesis and Preclinical Evaluation of a Brain-Permeable PET Tracer for P2Y12 Receptor Imaging in the BrainEmanuel Joseph, Lea H Kunze, Rebecca Schaefer, et al.
Oncotarget|June 4, 2016
The impact of 177Lu-octreotide therapy on 99mTc-MAG3 clearance is not predictive for late nephropathyRudolf A Werner, Seval Beykan, Takahiro Higuchi, et al.
Plant, Cell & Environment|November 24, 2020
Rethinking temperature effects on leaf growth, gene expression and metabolism: Diel variation mattersLukas Kronenberg, Steven Yates, Shiva Ghiasi, et al.
Clinical Nuclear Medicine|February 3, 2015
SPECT- and PET-based patient-tailored treatment in neuroendocrine tumors: a comprehensive multidisciplinary team approachR A Werner, Christina Bluemel, M Lassmann, et al.
Clinical Nuclear Medicine|November 10, 2022
Impact of 68 Ga-FAPI-04 PET/CT on Staging and Therapeutic Management in Patients With Digestive System TumorsAleksander Kosmala, Sebastian E Serfling, Wiebke Schlötelburg, et al.
Neuroimage|April 16, 2026
Dynamic Regional Divergence of SV2A Expression in a Mouse Model of Primary Tauopathy: A Longitudinal Multi-Tracer PET StudyYunlei Li, Artem Zatcepin, Giovanna Palumbo, et al.
Pageof 136